This study aimed to determine whether sustained stimulation with thyrotropin-releasing hormone (TRH), a peptide with important physiological functions, can possibly affect expression of plasma membrane proteins in HEK293 cells expressing high levels of TRH receptor and G(11)alpha protein. Our previous experiments using silver-stained two-dimensional polyacrylamide gel electrophoretograms did not reveal any significant changes in an overall composition of membrane microdomain proteins after long-term treatment with TRH of these cells (Matousek et al. 2005 Cell Biochem Biophys 42: 21-40). Here we used a purified plasma membrane fraction prepared by Percoll gradient centrifugation and proteins resolved by 2D electrophoresis were stained with SYPRO Ruby gel stain. The high enrichment in plasma membrane proteins of this preparation was confirmed by a multifold increase in the number of TRH receptors and agonist stimulated G-protein activity, compared to postnuclear supernatant. By a combination of these approaches we were able to determine a number of clearly discernible protein changes in the plasma membrane-enriched fraction isolated from cells treated with TRH (1 x 10(-5) M, 16 h): 4 proteins disappeared, the level of 18 proteins decreased and the level of 39 proteins increased. Our concomitant immunochemical determinations also indicated a clear down-regulation of G(q/11)alpha proteins in preparations from hormone-treated cells. In parallel, we observed decrease in caspase 3 and alterations in some other apoptotic marker proteins, which were in line with the presumed antiapoptotic effect of TRH.

Faculty of Science Department of Physiology Charles University Vinicna 7 Prague Czech Republic

000      

03419naa a2200433 a 4500

001      

bmc12008651

003      

CZ-PrNML

005      

20141106104225.0

008      

120316s2010 xxu eng||

009      

AR

040    __

$a ABA008 $b cze $d ABA008

041    0_

$a eng

044    __

$a xxu

100    1_

$a Drastichová, Z. $u Faculty of Science, Department of Physiology, Charles University, Vinicna 7, Prague, Czech Republic. $7 _AN051173

245    10

$a Protein alterations induced by long-term agonist treatment of HEK293 cells expressing thyrotropin-releasing hormone receptor and G11alpha protein / $c Z Drastichova, L Bourova, L Hejnova, P Jedelsky, P Svoboda, J Novotny

520    9_

$a This study aimed to determine whether sustained stimulation with thyrotropin-releasing hormone (TRH), a peptide with important physiological functions, can possibly affect expression of plasma membrane proteins in HEK293 cells expressing high levels of TRH receptor and G(11)alpha protein. Our previous experiments using silver-stained two-dimensional polyacrylamide gel electrophoretograms did not reveal any significant changes in an overall composition of membrane microdomain proteins after long-term treatment with TRH of these cells (Matousek et al. 2005 Cell Biochem Biophys 42: 21-40). Here we used a purified plasma membrane fraction prepared by Percoll gradient centrifugation and proteins resolved by 2D electrophoresis were stained with SYPRO Ruby gel stain. The high enrichment in plasma membrane proteins of this preparation was confirmed by a multifold increase in the number of TRH receptors and agonist stimulated G-protein activity, compared to postnuclear supernatant. By a combination of these approaches we were able to determine a number of clearly discernible protein changes in the plasma membrane-enriched fraction isolated from cells treated with TRH (1 x 10(-5) M, 16 h): 4 proteins disappeared, the level of 18 proteins decreased and the level of 39 proteins increased. Our concomitant immunochemical determinations also indicated a clear down-regulation of G(q/11)alpha proteins in preparations from hormone-treated cells. In parallel, we observed decrease in caspase 3 and alterations in some other apoptotic marker proteins, which were in line with the presumed antiapoptotic effect of TRH.

590    __

$a bohemika - dle Pubmed

650    02

$a apoptóza $x fyziologie $7 D017209

650    02

$a western blotting $7 D015153

650    02

$a buněčné linie $7 D002460

650    02

$a 2D gelová elektroforéza $7 D015180

650    02

$a exprese genu $x fyziologie $x účinky léků $7 D015870

650    02

$a lidé $7 D006801

650    02

$a membránové proteiny $x metabolismus $x účinky léků $7 D008565

650    02

$a protein-serin-threoninkinasy $x metabolismus $7 D017346

650    02

$a receptory thyroliberinu $x metabolismus $7 D018025

650    02

$a hormon uvolňující thyreotropin $x metabolismus $7 D013973

650    02

$a hormon uvolňující thyreotropin $7 D013973

655    _2

$a práce podpořená grantem $7 D013485

700    1_

$a Bouřová, L.

700    1_

$a Hejnová, Lucie, $d 1970- $7 xx0073809

700    1#

$a Jedelský, Petr $7 ola2017971194

700    1_

$a Svoboda, Petr, $d 1949- $7 jn20000710631

700    1_

$a Novotný, Jiří, $d 1959- $7 xx0071144

773    0_

$t Journal of Cellular Biochemistry $p J Cell Biochem $g Roč. 109, č. 1 (2010), s. 255-264 $w MED00002577 $x 0020-8868

773    0_

$p J Cell Biochem $g 109(1):255-64, 2010 Jan 1

910    __

$a ABA008 $b x $y 4 $z 0

990    __

$a 20120319124606 $b ABA008

991    __

$a 20141106104234 $b ABA008

999    __

$a ok $b bmc $g 901995 $s 765546

BAS    __

$a 3

BMC    __

$a 2010 $b 109 $c 1 $d 255-264 $m Journal of cellular biochemistry $x MED00002577

LZP    __

$a 2012-1Q10/